Pharmaceutical aerosol formulation

Details Pharmaceutical aerosol formulation Pharmaceutical aerosol formulation

2007-01-16

2007-01-16

Richter, Johann R. (Department: 1616)

Drug, bio-affecting and body treating compositions

Effervescent or pressurized fluid containing

Organic pressurized fluid

C514S025000, C514S061000

Reexamination Certificate

active

10451162

ABSTRACT:
The invention relates to a pharmaceutical aerosol formulation comprising a surfactant that is an alkyl-polyglycoside of formula I, wherein DP is the average degree of polymerisation and has a value of from 1 to 4, and R is an alkyl chain or a mixture of alkyl chains having a chain length of from 6 to 22 carbon atoms; or a derivative thereof for the administration of a medicament for inhalation.

REFERENCES:
patent: 6080387 (2000-06-01), Zhou et al.
patent: 6080869 (2000-06-01), Bonnert et al.
patent: 6143277 (2000-11-01), Ashurst et al.
patent: 6482392 (2002-11-01), Zhou et al.
patent: WO 95/00151 (1995-01-01), None
patent: WO 96/19198 (1996-06-01), None
patent: WO 97/47286 (1997-12-01), None
patent: WO 98/30244 (1998-07-01), None
patent: WO 00/19980 (2000-04-01), None
CAPLUS Abstract, “Alkyl glucoside-based aerosol type foam products,” Ascension No. 1997:328726, document No. 126:306557, corresponding to Japanese Patent JP 09059606, published Mar. 4, 1997.

Affiliated with

Also associated with

Rating

Pharmaceutical aerosol formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical aerosol formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical aerosol formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3757229